Related Experiment Videos
Smad4 transcriptional pathways and angiogenesis
Irmgard Schwarte-Waldhoff1, Wolff Schmiegel
1Ruhr-Universität Bochum, Medizinische Universitätsklinik, Knappschaftskrankenhaus, Germany. Irmgard.Schwarte-Waldhoff@ruhr-uni-bochum.de
International Journal of Gastrointestinal Cancer
|March 8, 2003
Summary
Restoring the Smad4 tumor suppressor gene suppressed gastrointestinal cancer growth in vivo. Smad4
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Smad4 (DPC4) is a tumor suppressor gene frequently inactivated in gastrointestinal cancers.
- Smad4 is a key intracellular mediator of TGF-beta signaling, which normally inhibits epithelial cell growth.
- Tumor cells often exhibit resistance to TGF-beta, and Smad4 loss is presumed to contribute to this resistance.
Purpose of the Study:
- To investigate the tumor suppressor functions of Smad4 by restoring its expression in deficient cancer cells.
- To elucidate the mechanisms by which Smad4 suppresses tumor growth beyond TGF-beta signaling.
Main Methods:
- Stable re-expression of Smad4 in human colon and pancreatic cancer cell lines.
- In vivo tumor growth assessment in nude mice.
- In vitro cell growth assays.
- Analysis of gene expression related to angiogenesis (VEGF, TSP-1).
Main Results:
- Smad4 re-expression potently suppressed tumor growth in vivo.
- Smad4 restoration did not significantly suppress tumor cell growth in vitro or restore TGF-beta responsiveness.
- Smad4 influenced angiogenesis by decreasing vascular endothelial growth factor (VEGF) and increasing thrombospondin-1 (TSP-1) expression.
Conclusions:
- Smad4's tumor suppressor function extends beyond TGF-beta pathway mediation.
- Loss of Smad4 and acquisition of TGF-beta resistance may be independent events in tumorigenesis.
- Smad4 regulates tumor growth through the control of angiogenesis, representing a novel tumor suppression mechanism.